Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Meloxicam launched in Great Britain

Sep. 27, 1996

Development of COX-2 inhibitors at Searle

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

U.S. patent covers hemopoietic regulator with potential in rheumatoid arthritis

Sep. 27, 1996

Monoclonal antibody effective in rheumatoid arthritis

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Progress in arthritis at Toyama

Sep. 13, 1996

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...